Alaris Medical $200 million eight-year notes talked at 7½% area, pricing Wednesday afternoon

By Paul A. Harris

St. Louis, June 24 - Price talk of 7½% area emerged Tuesday on Alaris Medical Inc.'s upcoming sale of $200 million eight-year senior subordinated notes, according to a market source.

The deal is expected to price Wednesday afternoon, the source added.

Bear Stearns & co., Citigroup and UBS Investment Bank are joint bookrunners on the off-the-shelf deal. CIBC World Markets and Jefferies & Co. are co-managers.

The notes will be non-callable for four years.

Proceeds will be used to repurchase existing debt and for general corporate purposes.

The San Diego company develops solutions for medication safety.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.